Evidence map›Paper›PMID 41117875›Full record

ArticleNeurotoxicity research2025

Behavioral Alterations and Cholinergic Modulation in Zebrafish Acutely Exposed To Tyrosine.

Isabela da Silva Lemos, Francine Fiorot Prando de Vasconcelos, Guilherme da Silva Lodetti, Carolina Giassi Alano, Flávia Karine Rigo, Rahisa Scussel, Fabio Henrique Baia, Eduardo Pacheco Rico, Emilio Luiz Streck

Abstract read
PubMed Publisher
In one paragraph

Article in Neurotoxicity research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Isabela da Silva LemosLaboratório de Doenças Neurometabólicas, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense. Universitária Avenue, Criciúma, 1105, 88806-000, Santa Catarina, Brazil.ORCID http://orcid.org/0000-0003-1715-7488
Francine Fiorot Prando de VasconcelosLaboratório de Doenças Neurometabólicas, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense. Universitária Avenue, Criciúma, 1105, 88806-000, Santa Catarina, Brazil.
Guilherme da Silva LodettiLaboratório de Psiquiatria Translacional, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, 88806-000, SC, Brasil.ORCID http://orcid.org/0000-0002-1475-4554
Carolina Giassi AlanoLaboratório de Doenças Neurometabólicas, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense. Universitária Avenue, Criciúma, 1105, 88806-000, Santa Catarina, Brazil.ORCID http://orcid.org/0000-0001-8710-036X
Flávia Karine RigoLaboratório de Fisiopatologia Experimental, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, 88806-000, SC, Brasil.ORCID http://orcid.org/0000-0003-2976-8841
Rahisa ScusselLaboratório de Fisiopatologia Experimental, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, 88806-000, SC, Brasil.ORCID http://orcid.org/0000-0002-0931-604X
Fabio Henrique BaiaFaculdade de Medicina, Universidade de Rio Verde. Fazenda Fontes do Saber, Campus universitário, 75901-970, Rio Verde, GO, Brasil.ORCID http://orcid.org/0000-0002-4084-4828
Eduardo Pacheco RicoLaboratório de Psiquiatria Translacional, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, 88806-000, SC, Brasil.ORCID http://orcid.org/0000-0003-0019-328X
Emilio Luiz StreckLaboratório de Doenças Neurometabólicas, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense. Universitária Avenue, Criciúma, 1105, 88806-000, Santa Catarina, Brazil. emiliostreck@unesc.net.ORCID http://orcid.org/0000-0002-2859-4678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tyrosinemia type II (Richner-Hanhart syndrome) is a rare disorder caused by mutations in the TAT gene, leading to elevated blood tyrosine and impaired metabolism. It presents with oculocutaneous symptoms, retinal tyrosine crystals, and neurological issues. Elevated tyrosine disrupts brain metabolism, neurotransmitters, and neurotrophic factors, causing neuroinflammation and affecting brain function. The exact mechanism of neurological damage is unclear, and the impact of dietary intervention on cognition is uncertain. While rodent models are commonly used, zebrafish are emerging as a cost-effective, genetically similar alternative for studying tyrosinemia type II. Thus, this study aims to determine whether acute exposure of zebrafish to elevated tyrosine concentrations can reproduce early central nervous system alterations associated with tyrosinemia type II. Zebrafish were exposed via immersion to 1 mM or 2 mM tyrosine for 1-24 h, with a total of 180 animals used across assays. Behavioral analysis was conducted using the novel tank test, and cholinergic and oxidative stress markers were assessed. Brain tyrosine levels were measured centrally. Exposure to 1 mM tyrosine for 24 h resulted in the highest brain accumulation, suggesting a non-linear dose-response. Behavioral testing revealed decreased locomotor activity and exploratory behavior, and ChAT activity was reduced in both exposure groups. No significant changes were observed in oxidative stress or protein damage. These findings indicate that acute tyrosine exposure induces early behavioral and cholinergic alterations without detectable oxidative stress, supporting the use of zebrafish as a preliminary model to study early neurochemical disturbances such in tyrosinemia type II. Further studies should explore different life stages, sex-specific responses, chronic exposure, and precise tyrosine kinetics, including potential non-linear effects due to the LAT1 transporter, to clarify mechanisms underlying neurotoxicity and improve translational relevance.

Indexed as

Behavior, AnimalBrainTyrosineAnimalsCholine O-AcetyltransferaseDisease Models, AnimalExploratory BehaviorFemaleLocomotionMaleOxidative StressTyrosinemiasZebrafishCholine O-AcetyltransferaseTyrosineAnxiety-like behaviorCholinergic systemInborn errors of metabolismNovel tank testTyrosine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.